Insulin resistance in type 1 diabetes is more common than most people realize, and it responds to many of the same strategies used in type 2 diabetes, with some important differences. If you’re needing more than 1 unit of insulin per kilogram of body weight per day and still struggling with blood sugar control, insulin resistance is likely part of the picture. The good news: a combination of lifestyle changes, dietary adjustments, technology, and sometimes additional medications can meaningfully reduce your insulin needs and improve your time in range.
Why Insulin Resistance Develops in Type 1
The old idea that type 1 diabetes is purely about insulin deficiency doesn’t hold up. Type 1 is a more heterogeneous disease than once thought, and insulin resistance plays a real role for many people living with it. The causes are different from type 2, though. In type 1, the way you receive insulin is itself part of the problem: injecting insulin under the skin eliminates the natural daily rhythm of insulin levels and reverses the normal distribution, sending more insulin to your muscles and fat than to your liver. This “iatrogenic hyperinsulinemia” actually worsens resistance over time.
On top of that, several interconnected processes drive resistance. High blood sugars reduce the ability of muscle cells to pull glucose from the bloodstream. Excess fat accumulates in the liver, muscles, and heart when lipid metabolism gets disrupted. Low-grade inflammation from the autoimmune process itself releases compounds that interfere with insulin signaling. And oxidative stress, a byproduct of fluctuating blood sugars and disrupted energy metabolism, compounds all of it. These mechanisms feed each other, which is why addressing insulin resistance usually requires more than one approach.
Strength Training Has Outsized Benefits
If you do one thing to improve insulin sensitivity, make it resistance training. When muscles contract during strength exercises, they pull glucose out of the blood through a pathway that works independently of insulin. This insulin-like effect is unique to exercise and persists: the mechanisms that enhance glucose uptake in skeletal muscle stay elevated for up to 48 hours after a workout. That’s two full days of improved sensitivity from a single session.
Over time, building muscle mass creates a larger “sink” for glucose. More muscle means more glucose uptake at baseline, fewer highs, and less exogenous insulin needed. Resistance training also has a practical advantage over cardio for people with type 1. It causes a smaller glucose drop during the activity itself, which means fewer lows mid-workout, while still producing longer-lasting reductions in post-exercise blood sugar. A systematic review found that resistance training programs led to significant reductions in HbA1c, likely because increased muscle strength optimized the amount of glucose burned during each session.
Starting with two to three sessions per week, focusing on compound movements like squats, deadlifts, rows, and presses, gives you the most glucose-disposing muscle engagement per session. You’ll likely need to adjust your insulin doses downward as your sensitivity improves, so working closely with your care team during the first few weeks is important.
Dietary Changes That Lower Insulin Needs
Reducing carbohydrate intake directly lowers the amount of insulin you need, which in turn reduces the hyperinsulinemia that drives resistance. In a 12-week trial, adults with type 1 who followed a low-carbohydrate diet (25 to 75 grams per day) reduced their total daily insulin from 65 to 49 units and increased their time in range from 59% to 74%. A separate crossover trial found that a moderate low-carb approach (around 100 grams per day) reduced glycemic variability and time spent in hypoglycemia compared to a higher-carb diet of 250 grams per day.
You don’t necessarily need to go very low carb to see benefits. Even shifting toward fewer processed carbohydrates, more fiber, and more protein and healthy fats at each meal can smooth out glucose swings and reduce bolus insulin requirements. The key mechanism is simple: less carbohydrate means less insulin, and less circulating insulin means your tissues stay more responsive to it. One caution worth noting: very low-carb and ketogenic diets carry additional risk if you’re also taking certain medications (more on that below), so any major dietary shift should be planned with your endocrinologist.
Metformin as an Add-On Medication
Metformin is the most studied add-on medication for insulin resistance in type 1. It works primarily by reducing glucose output from the liver, which helps lower the baseline insulin you need between meals. In clinical trials, people with type 1 who added metformin to their insulin regimen saw their insulin requirements decrease, while those on insulin alone saw their requirements climb. The typical dose studied was around 2,000 mg per day, usually built up gradually to minimize GI side effects like nausea and diarrhea.
Metformin won’t dramatically change your HbA1c on its own, but the reduction in total daily insulin is the real goal. Lower circulating insulin helps break the cycle where excess insulin promotes fat storage, which promotes more resistance, which demands more insulin. If your daily insulin dose has been creeping upward despite stable eating and exercise habits, metformin is often the first pharmacological step your doctor will consider.
GLP-1 Medications for Weight and Appetite
GLP-1 receptor agonists (the drug class that includes semaglutide and tirzepatide) have generated significant interest for type 1 diabetes, particularly for people carrying extra weight. These medications slow gastric emptying, increase satiety, reduce glucagon release, and improve glucose uptake in muscles. For people with type 1 who have developed insulin resistance partly due to weight gain, the appetite-suppressing and weight-loss effects are the primary draw.
The evidence in type 1 specifically is still developing. Randomized trials using older, less potent versions of these drugs (like liraglutide) haven’t consistently shown improvements in HbA1c or insulin dose reduction in type 1 populations. But many of those studies weren’t designed to target people with elevated BMI, who are the most likely to benefit. The newer, more potent agents like semaglutide and tirzepatide produce substantially more weight loss, and the appetite suppression that drives their effect works regardless of diabetes type. In one documented case, a person with type 1 and significant insulin resistance who started tirzepatide saw a 20% reduction in total daily insulin and an improvement in time in range from 55% to 72% within two months.
Automated Insulin Delivery Systems
Closed-loop insulin pumps (also called automated insulin delivery, or AID, systems) don’t fix insulin resistance directly, but they manage its consequences more effectively than manual dosing. These systems use continuous glucose monitor data to adjust basal insulin delivery in real time, responding to rising or falling glucose levels faster than you could with injections. Some systems, like the Omnipod 5, adapt their basal rate calculations using your total daily insulin from the previous wear period, personalizing delivery as your needs shift.
For someone with insulin resistance, this adaptive dosing helps prevent the persistent highs that worsen resistance through glucotoxicity. The limitation is that current systems can’t automatically tell the difference between active and inactive states. Exercise still requires preplanning: you’ll need to enable activity profiles that raise the glucose target or reduce the sensitivity factor before you start moving. The slower action of subcutaneous insulin, combined with no automatic glucagon delivery, means the system can’t fully compensate for rapid drops during workouts. Still, for day-to-day management, AID systems reduce glycemic variability, which helps keep insulin sensitivity from deteriorating further.
SGLT2 Inhibitors: Effective but Risky
SGLT2 inhibitors, which work by causing the kidneys to excrete excess glucose in urine, can reduce insulin needs and improve glucose control in type 1. But they come with a serious and specific risk: euglycemic diabetic ketoacidosis (DKA). This is a form of DKA where blood sugar levels look normal or only slightly elevated, which means the usual warning sign of very high glucose is absent. Case reports show substantial delays in recognizing this condition, making it genuinely dangerous.
If an SGLT2 inhibitor is considered for you, several safeguards matter. Therapy should start at the lowest available dose. In clinical trials, very low doses showed effectiveness comparable to higher doses but with a DKA rate similar to placebo, while standard doses significantly increased risk. Insulin doses need careful, gradual reduction (typically 10 to 20% for people already well controlled) with frequent glucose monitoring or CGM. You should know how to check ketones and understand when to hold the medication: before heavy exercise, during illness, if you’re dehydrated, or if you’re drinking more alcohol than usual. These drugs should not be used alongside low-carb or ketogenic diets, as the combination raises ketosis risk considerably and makes it harder to interpret ketone readings.
How to Know If You Have Insulin Resistance
The simplest clinical marker is your total daily insulin dose relative to your weight. Needing more than 1 unit per kilogram per day indicates insulin resistance. Needing more than 2 units per kilogram per day is classified as severe resistance. So if you weigh 80 kg (about 176 pounds) and you’re using more than 80 units of insulin daily, resistance is likely a factor. Other signs include weight gain (especially around the midsection), darkened skin patches on the neck or underarms (called acanthosis nigricans), and persistently high blood sugars despite escalating insulin doses.
Tracking your total daily insulin over time is one of the most useful things you can do. If your doses are steadily climbing while your diet and activity haven’t changed, that trend itself is a signal. Many insulin pumps and CGM apps report this data automatically, making it easier to spot the pattern early and intervene before resistance becomes severe.